Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: a randomized controlled trial
Fluctuations in dietary methionine intake do not alter plasma homocysteine concentration in healthy men
Rapid weight loss Jennifer Hardy Jun 97 min read AstraZeneca Moves Toward the Oral GLP-1 Market with Elecoglipron The race to develop effective oral GLP-1 medications for obesity is heating up, and AstraZeneca is officially making its move
doi: 10.1161/CIRCULATIONAHA.116.025338 Summary Keywords gut microbiota, cardiovascular disease, metabolites, trimethylamine, atherosclerosis, hypertension Citation Rahman MM, Islam F, -Or-Rashid MH, Mamun AA, Rahaman MS, Islam MM, Meem AFK, Sutradhar PR, Mitra S, Mimi AA, Emran TB, Fatimawali, Idroes R, Tallei TE, Ahmed M and Cavalu S (2022) The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation